Fig. 1
From: Artocarpesin acts on human platelet aggregation through inhibition of cyclic nucleotides and MAPKs
Effects of artocarpesin on platelet aggregation, half maximal inhibitory concentration, and cytotoxicity. A Chemical structure of artocarpesin. B Effect of artocarpesin on collagen-induced human platelet aggregation. C Half maximal inhibitory concentration (IC50) value of artocarpesin in collagen-induced human platelet aggregation. D Effect of artocarpesin on cytotoxicity. Platelet aggregation and cytotoxicity were carried out as described in “Materials and Methods” section. The data are expressed as the mean ± standard deviation (n = 4). *p < 0.05, **p < 0.01 versus each agonist-stimulated human platelets. NS, not significant